Regression analysis identified AHI and IGFBP4 as independent predictors of FSTL1 levels, reinforcing the notion that OSA severity and metabolic alterations directly influence FSTL1 levels. Here, IGFBP4 is linked to obstructive sleep apnea syndrome.